24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot forĀ  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major Journal
Questions and AnswersLinks
Related Topics

Diabetes

Could COVID-19 Accelerate Alzheimer's Symptoms?

HealthDay News
by By Dennis Thompson HealthDay Reporter
Updated: Jul 30th 2021

new article illustration

FRIDAY, July 30, 2021 (HealthDay News) -- COVID-19 can kill you. It can rob you of your breath, cause strange blood clots, and prompt side effects that last for months after you're over the initial infection.

It's also possible that COVID-19 might impact the human brain in ways that could promote the onset of Alzheimer's disease, a new study reports.

Severely ill COVID-19 patients display biological evidence of brain injury and inflammation as well as early markers of Alzheimer's, according to data gathered by an international consortium reviewing the coronavirus' effects on brain health.

This includes an uptick in tau, a sticky protein that forms tangles in the brains of later-stage Alzheimer's patients, said study author Dr. Thomas Wisniewski. He is a professor of neurology, pathology and psychiatry at New York University Grossman School of Medicine.

COVID-19 "accelerates Alzheimer's biomarkers, and if you have preexisting Alzheimer's or related dementias, you're much more likely to have neurological complications and more severe disease," Wisniewski said. "The fact that COVID can increase Alzheimer's biomarkers suggests that long-term it could be a predisposing factor to accelerating the pathology."

The findings were presented Thursday at the Alzheimer's Association's annual meeting, which is being held in Denver and online. Such research is considered preliminary until published in a peer-reviewed journal.

In this study, researchers evaluated 310 patients admitted to NYU Langone Health in New York City with COVID-19.

Of those, about half developed neurological symptoms, most commonly confusion due to toxic-metabolic encephalopathy (TME), a condition in which an infection disrupts brain function by causing chemical abnormalities.

COVID-19 patients who developed TME were more likely than those without to have elevated levels of biological markers in their blood related to brain injury and Alzheimer's, the investigators found.

These markers also appeared to be linked with blood indicators of inflammation, suggesting that COVID-19 could cause the brain to swell and potentially damage neurons, the researchers added.

Although more research is required, the evidence suggests that COVID-19 might do enough harm to the brain that it could predispose an otherwise healthy person to later develop dementia or Alzheimer's, Wisniewski said.

It also could be that people already at risk for Alzheimer's would be pushed further down that dark path after a case of COVID-19, he added.

"Particularly for anyone who's predisposed to any of these neurodegenerative conditions, anyone who's older, this looks like a very significant risk of getting COVID that can push you over the brink," Wisniewski said.

The finding results from a collaboration between the Alzheimer's Association and representatives from nearly 40 countries to evaluate the long-term consequences of COVID-19 on the brain and nervous system.

Heather Snyder, vice president of scientific and medical relations for the Alzheimer's Association, said, "One of the hallmark symptoms by which we define COVID-19 is a loss of taste or smell. That's an indicator that something is going on in the brain, because those are functions our brain controls."

There's also concern about "brain fog" among COVID-19 sufferers and survivors, she added.

"We are seeing that individuals are experiencing changes in their memory, their thinking, their reasoning, their behavior," Snyder said.

"What we don't know is, does that persist, is it able to be reversed, and what that means in terms of long-term impact or risk of Alzheimer's or other cognitive changes," Snyder continued. "Those are some of the questions we need to be asking."

There's a simple fix for folks who want to protect their brain health against COVID-19, Snyder added.

"If you're not yet vaccinated, get vaccinated. Protect yourself," she said.

More information

Johns Hopkins has more on COVID's effects on the brain.

SOURCES: Thomas Wisniewski, MD, professor, neurology, pathology and psychiatry, New York University Grossman School of Medicine, New York City; Heather Snyder, PhD, vice president, scientific and medical relations, Alzheimer's Association